No profile data available.
Cosmos Health Inc. (COSM) is a healthcare company in the bulk drug suppliers industry, based in Thessaloniki, Greece, with about 163 full-time employees.
It reported revenue of $65.27 million for fiscal year 2025, up 19.9% from fiscal year 2024, and net income of -$19.14 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $18.99 million, up 28.8% from a year before. Its largest business segment, Wholesale, brought in 91% of segment revenue in fiscal year 2025; Greece was the largest region with 97%. Its market capitalization was $33.80 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.
Cosmos Health reported $65.27 million in revenue for fiscal year 2025, up 19.9% from $54.43 million in fiscal year 2024. In Q2 2026 revenue was $18.99 million.
Wholesale, with $59.32 million or 91% of segment revenue in fiscal year 2025. Next: Nutraceuticals & Pharmaceuticals (7%) and Pharma Manufacturing (3%).
Greece: 97% of revenue by region in fiscal year 2025, followed by United Kingdom (2%).
$33.80 million as of October 9, 2026.
Listed companies of a similar size in the same industry (bulk drug suppliers) include Alfresa Holdings Corporation (ARHCF), 111, Inc. (YI), China Medicine Corporation (CHME), Ridgetech, Inc. (RDGT).